Free Research Compliance Resources During COVID-19 Crisis
COLUMBIA, Md., March 26, 2020 /PRNewswire/ -- Advarra announces the availability of free resources to support and enable the clinical research community and ongoing research during the coronavirus disease (COVID-19) crisis. This includes complimentary transfer of IRB oversight, access to a new version of Forte eRegulatory management software, eReg Lite, and a dedicated "Ask Advarra" resource for rapid guidance on emerging issues impacted by COVID-19.
"Advarra has been reviewing more COVID-19 research since the beginning with priority reviews and reduced fees, but we wanted to do more," said Robann Cunningham, Chief Commercial Officer at Advarra. "COVID-19 has not adversely impacted Advarra's business thanks to our virtual capabilities, and we feel it is our responsibility to give back since we have the expertise, depth of resources, and technology to keep research moving forward during these challenging times."
Transfer of IRB Oversight
Customized Support and Online Resources
Other Virtual Support and Consulting
Advarra is proud to partner with the research community to fight COVID-19. The organization remains vigilant in its mission to provide thought leadership and keep researchers informed as the community navigates the clinical trial landscape together during this crisis.
View original content to download multimedia:http://www.prnewswire.com/news-releases/free-research-compliance-resources-during-covid-19-crisis-301030504.html